SE Borggreve, R De Vries, RP Dullaart - European journal of clinical investigation, 2003 - pt.wkhealth.com ABCA1: ATP binding cassette transporter 1; Apo: apolipoprotein; CETP:
cholesteryl ester transfer protein; EL: endothelial lipase; ELISA: enzyme-linked
immunoabsorbent assay; FFA: free fatty acid; HDL: high-density lipoprotein; ... Cited by 98 - Related articles - BL Direct - All 6 versions
A Tenenbaum, M Motro, EZ Fisman - Cardiovascular Diabetology, 2005 - biomedcentral.com There are three peroxisome proliferator-activated receptors (PPARs) subtypes
which are commonly designated PPAR alpha, PPAR gamma and PPAR beta/delta. PPAR
alpha activation increases high density lipoprotein (HDL) cholesterol ... Cited by 94 - Related articles - Cached - All 13 versions
- ►alfediam.org [PDF] V Large, O Peroni, D Letexier, H Ray, M … - Diabetes and Metabolism, 2004 - Elsevier Adipose tissue is considered as the body's largest storage organ for energy in
the form of triacylglycerols, which are mobilized through lipolysis process, to
provide fuel to other organs and to deliver substrates to liver for ... Cited by 72 - Related articles - All 4 versions
F Diraison, PH Moulin, M Beylot - Diabetes and Metabolism, 2003 - Elsevier To clarify these mechanisms we measured triglyceride secretion rate and the
contributions of hepatic lipogenesis and reesterification of non-esterified
fatty acids (NEFA) to this secretion in healthy subjects and in patients ... Cited by 64 - Related articles - All 3 versions
- ►bentham.org [PDF] … SS Daskalopoulou, DP Mikhailidis, MS Elisaf - Current Vascular Pharmacology, 2005 - ingentaconnect.com Abstract: Disturbances of lipoprotein metabolism represent one of the most
important risk factors for vascular events. However, dyslipidaemic patients
often have a number of additional abnormalities (such as endothelial ... Cited by 44 - Related articles - All 5 versions
- ►praeventia.ca [PDF] M Beylot - British Journal of Nutrition, 2007 - Cambridge Univ Press Studies in rodents show that inulin and oligofructose can reduce the plasma
levels of cholesterol and triacylglycerols (TG). In addition, they can oppose TG
accumulation in liver and have favourable effects on hepatic steatosis. The ... Cited by 43 - Related articles - All 8 versions
KK Wu, TJ Wu, J Chin, LJ Mitnaul, M … - Atherosclerosis, 2005 - Elsevier Diabetes mellitus is one of the major risk factors associated with
atherosclerosis and coronary heart disease but the mechanistic links between the
disease and atherosclerosis are not well understood. In this study, we ... Cited by 40 - Related articles - All 6 versions
JC Fruchart, P Duriez - Drugs of Today, 2006 - journals.prous.com Epidemiological studies have shown that hypertriglyceridemia and low
HDL-cholesterol were both associated with an increased risk of coronary heart
disease. Furthermore, hypertriglyceridemia is now recognized as an ... Cited by 38 - Related articles - All 5 versions
- ►nursing2008.com GM Keating, KF Croom - Drugs, 2007 - ingentaconnect.com 0012-6667/07/0001-0121/$49.95/0 2007 Adis Data Information BV. All rights
reserved. ... A Review of its Use in Primary Dyslipidaemia, the Metabolic
Syndrome and Type 2 Diabetes Mellitus ... Gillian M. Keating and ... Cited by 37 - Related articles - BL Direct - All 10 versions
